Multiple myeloma genetic discovery promises better treatment:
This article was originally published in Clinica
Executive Summary
US researchers have categorised four distinguishing gene patterns for the blood cancer multiple myeloma, which could allow doctors to better predict how patients will respond to current treatments. The team, which included collaborators from the Dana-Farber Cancer Institute in Boston, Massachusetts, said that patients with each gene pattern can be correlated with different clinical outcomes. The findings could lead to the design of drugs targeted at these specific gene patterns. The results appear in the April issue of Cancer Cell. Mutiple myeloma is the second most common form of blood cancer after non-Hodgkin's lymphoma.
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.